Diagnostic Biomarkers in Metabolomics

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker reveals further information to presently existing clinical and pathological analysis. It facilitates screening and detecting the disease, monitoring the progression of the disease, and predicting the diagnosis and survival after clinical intervention. A biomarker can also be used to evaluate the process of drug development and optimally to improve the efficacy and safety of disease treatment by enabling physicians to tailor treatment for individual patients. These emerging biomarkers will be beneficial and critical in developing new and clinically reliable indicators that will have a high specificity for the diagnosis.
  • Metabolite platform for validation of biomarkers
  • Biomarkers in drug development
  • Disease related biomarkers
  • Imaging biomarkers
  • Metabolomics in biomarker discovery

Related Conference of Diagnostic Biomarkers in Metabolomics

April 16-17, 2020

16th World Congress on Structural Biology

Amsterdam, Netherlands
April 20-21, 2020

11th Tissue Science and Regeneration Congress

Kuala Lumpur, Malaysia
June 28-30 2020

globalbiotechnology-cs-2020

June 28-30 2020

oilgas-cs-2020

June 28-30 2020

BEHAVIOURAL SCIENCE-2020

June 28-30 2020

Bioinfo 2020

July 17-18, 2020

10th Glycobiology World Congress

Vienna, Austria
August 04,05 2020

12th Euro Biosensors & Bioelectronics Congress

Zurich, Switzerland
June 28-30 2020

NURSE PRACTITIONER 2020

September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
October 14-15, 2020

9th World Congress on Glycobiology & Glycochemistry

Rome, Italy
December 10-11, 2020

2nd European Pathology and Infectious Disease Conference

Abu Dhabi, UAE

Diagnostic Biomarkers in Metabolomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in